Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study.

Feng S, Chiu SS, Chan ELY, Kwan MYW, Wong JSC, Leung CW, Chung Lau Y, Sullivan SG, Malik Peiris JS, Cowling BJ.

Lancet Respir Med. 2018 Nov 12. pii: S2213-2600(18)30419-3. doi: 10.1016/S2213-2600(18)30419-3. [Epub ahead of print]

PMID:
30442587
2.

The value of neuraminidase inhibition antibody titers in influenza seroepidemiology.

Cowling BJ, Sullivan SG.

J Infect Dis. 2018 Jul 14. doi: 10.1093/infdis/jiy446. [Epub ahead of print] No abstract available.

PMID:
30011035
3.

A concern over terminology in vaccine effectiveness studies.

Cowling BJ, Sullivan SG.

Euro Surveill. 2018 Mar;23(10). doi: 10.2807/1560-7917.ES.2018.23.10.18-00103. No abstract available.

4.

Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing.

Sim SA, Leung VKY, Ritchie D, Slavin MA, Sullivan SG, Teh BW.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1490-1496. doi: 10.1016/j.bbmt.2018.03.004. Epub 2018 Mar 9.

PMID:
29530766
5.

Does influenza vaccination during early pregnancy really increase the risk of miscarriage?

Regan AK, Moore HC, Sullivan SG.

Vaccine. 2018 Apr 19;36(17):2227-2228. doi: 10.1016/j.vaccine.2017.12.033. Epub 2017 Dec 21. No abstract available.

PMID:
29274702
6.

Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine.

Paules CI, Sullivan SG, Subbarao K, Fauci AS.

N Engl J Med. 2018 Jan 4;378(1):7-9. doi: 10.1056/NEJMp1714916. Epub 2017 Nov 29. No abstract available.

7.

Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017.

Sullivan SG, Chilver MB, Carville KS, Deng YM, Grant KA, Higgins G, Komadina N, Leung VK, Minney-Smith CA, Teng D, Tran T, Stocks N, Fielding JE.

Euro Surveill. 2017 Oct;22(43). doi: 10.2807/1560-7917.ES.2017.22.43.17-00707.

8.

Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.

Rondy M, El Omeiri N, Thompson MG, Levêque A, Moren A, Sullivan SG.

J Infect. 2017 Nov;75(5):381-394. doi: 10.1016/j.jinf.2017.09.010. Epub 2017 Sep 18. Review.

9.

Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review.

Li L, Wong JY, Wu P, Bond HS, Lau EHY, Sullivan SG, Cowling BJ.

Am J Epidemiol. 2018 Feb 1;187(2):378-388. doi: 10.1093/aje/kwx270.

PMID:
28679157
10.

Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis.

Feng S, Cowling BJ, Kelly H, Sullivan SG.

Am J Epidemiol. 2018 Feb 1;187(2):389-397. doi: 10.1093/aje/kwx251.

PMID:
28641373
11.

Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.

Leung VKY, Carolan LA, Worth LJ, Harper SA, Peck H, Tilmanis D, Laurie KL, Slavin MA, Sullivan SG.

Vaccine. 2017 May 2;35(19):2558-2568. doi: 10.1016/j.vaccine.2017.03.063. Epub 2017 Apr 3.

PMID:
28385605
12.

Consecutive Influenza Infections in Both Adults and Children.

Arnott A, Carville K, Franklin L, Sullivan SG.

J Infect Dis. 2017 Feb 15;215(4):658-659. doi: 10.1093/infdis/jix016. No abstract available.

PMID:
28329041
13.

A brief overview of influenza surveillance systems in Australia, 2015.

Sullivan SG, Raupach J, Franklin LJ, Pennington K, Bareja C, de Kluyver R; and the National Influenza Surveillance Committee, for the Communicable Diseases Network Australia.

Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E351-E355. No abstract available.

PMID:
28278409
14.

Influenza surveillance in Australia.

Pennington K, Bareja C, Sullivan SG, Franklin LJ, Raupach J.

Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E315-E316. No abstract available.

PMID:
28278403
15.

Timely antiretroviral prophylaxis during pregnancy effectively reduces HIV mother-to-child transmission in eight counties in China: a prospective study during 2004-2011.

Wang Q, Wang L, Fang L, Wang A, Jin X, Wang F, Wang X, Qiao Y, Sullivan SG, Rutherford S, Zhang L.

Sci Rep. 2016 Oct 10;6:34526. doi: 10.1038/srep34526.

16.

Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ.

Am J Epidemiol. 2016 Sep 1;184(5):345-53. doi: 10.1093/aje/kww064.

17.

Frailty and influenza vaccine effectiveness.

Sullivan SG, Cowling BJ, Greenland S.

Vaccine. 2016 Sep 7;34(39):4645-6. doi: 10.1016/j.vaccine.2016.08.003. No abstract available.

PMID:
27578296
18.

Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment.

Fielding JE, Levy A, Chilver MB, Deng YM, Regan AK, Grant KA, Stocks NP, Sullivan SG.

Vaccine. 2016 Sep 22;34(41):4905-4912. doi: 10.1016/j.vaccine.2016.08.067. Epub 2016 Aug 28.

PMID:
27577556
19.

Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review.

Leung VK, Cowling BJ, Feng S, Sullivan SG.

Euro Surveill. 2016 Apr 21;21(16). doi: 10.2807/1560-7917.ES.2016.21.16.30202. Review.

20.

Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.

Feng S, Cowling BJ, Sullivan SG.

Vaccine. 2016 Mar 29;34(14):1672-9. doi: 10.1016/j.vaccine.2016.02.039. Epub 2016 Feb 23.

21.

Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season.

Barr IG, Vijaykrishna D, Sullivan SG.

Euro Surveill. 2016;21(4). doi: 10.2807/1560-7917.ES.2016.21.4.30118.

22.

How severe was the 2015 influenza season in Australia?

Fielding JE, Regan AK, Dalton CB, Chilver MB, Sullivan SG.

Med J Aust. 2016 Feb 1;204(2):60-1. No abstract available.

PMID:
26821099
23.
24.

"Crude Vaccine Effectiveness" Is a Misleading Term in Test-negative Studies of Influenza Vaccine Effectiveness.

Sullivan SG, Cowling BJ.

Epidemiology. 2015 Sep;26(5):e60. doi: 10.1097/EDE.0000000000000343. No abstract available.

25.

Inter-Seasonal Influenza is Characterized by Extended Virus Transmission and Persistence.

Patterson Ross Z, Komadina N, Deng YM, Spirason N, Kelly HA, Sullivan SG, Barr IG, Holmes EC.

PLoS Pathog. 2015 Jun 24;11(6):e1004991. doi: 10.1371/journal.ppat.1004991. eCollection 2015 Jun.

26.

The contrasting phylodynamics of human influenza B viruses.

Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, Stockwell TB, Fedorova NB, Zhou B, Spirason N, Kühnert D, Bošková V, Stadler T, Costa AM, Dwyer DE, Huang QS, Jennings LC, Rawlinson W, Sullivan SG, Hurt AC, Maurer-Stroh S, Wentworth DE, Smith GJ, Barr IG.

Elife. 2015 Jan 16;4:e05055. doi: 10.7554/eLife.05055.

27.

Who uses methadone services in China? Monitoring the world's largest methadone programme.

Sullivan SG, Wu Z, Rou K, Pang L, Luo W, Wang C, Cao X, Yin W, Liu E, Mi G; National Methadone Maintenance Treatment Working Group.

Addiction. 2015 Jan;110 Suppl 1:29-39. doi: 10.1111/add.12781.

PMID:
25533862
28.

Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.

Carville KS, Grant KA, Sullivan SG, Fielding JE, Lane CR, Franklin L, Druce J, Kelly HA.

Vaccine. 2015 Jan 3;33(2):341-5. doi: 10.1016/j.vaccine.2014.11.019. Epub 2014 Nov 22.

PMID:
25448093
29.

Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Sullivan SG, Feng S, Cowling BJ.

Expert Rev Vaccines. 2014 Dec;13(12):1571-91. doi: 10.1586/14760584.2014.966695. Epub 2014 Oct 28. Review.

30.

Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.

Levy A, Sullivan SG, Tempone SS, Wong KL, Regan AK, Dowse GK, Effler PV, Smith DW.

Vaccine. 2014 Oct 29;32(47):6312-8. doi: 10.1016/j.vaccine.2014.08.066. Epub 2014 Sep 16.

PMID:
25223268
31.

Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network.

Sullivan SG, Chilver MB, Higgins G, Cheng AC, Stocks NP.

Med J Aust. 2014 Jul 21;201(2):109-11.

PMID:
25045991
32.

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.

Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, Arkinstall R, Kelso A, Mcvernon J, Barr IG, Middleton D, Hurt AC.

J Antimicrob Chemother. 2014 Sep;69(9):2458-69. doi: 10.1093/jac/dku146. Epub 2014 May 19.

33.

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses.

Leang SK, Kwok S, Sullivan SG, Maurer-Stroh S, Kelso A, Barr IG, Hurt AC.

Influenza Other Respir Viruses. 2014 Mar;8(2):135-9.

34.

Continued drug use during methadone treatment in China: a retrospective analysis of 19,026 service users.

Sullivan SG, Wu Z, Cao X, Liu E, Detels R; National Methadone Maintenance Treatment Working Group.

J Subst Abuse Treat. 2014 Jul;47(1):86-92. doi: 10.1016/j.jsat.2013.12.004. Epub 2013 Dec 25.

35.

Re: Sullivan SG, Greenland S. Bayesian regression in SAS software. Int J Epidemiol 2013;42:308-17.

Sullivan SG, Greenland S.

Int J Epidemiol. 2014 Jun;43(3):974. doi: 10.1093/ije/dyt280. Epub 2014 Jan 24. No abstract available.

PMID:
24464189
36.

Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match.

Sullivan SG, Komadina N, Grant K, Jelley L, Papadakis G, Kelly H.

J Med Virol. 2014 Jun;86(6):1017-25. doi: 10.1002/jmv.23847. Epub 2013 Nov 8.

PMID:
24395730
37.

Time to first treatment interruption in the Chinese methadone maintenance treatment programme.

Sullivan SG, Wu Z, Detels R; National Methadone Maintenance Treatment Working Group.

Drug Alcohol Depend. 2013 Dec 1;133(2):427-32. doi: 10.1016/j.drugalcdep.2013.06.021. Epub 2013 Jul 26.

PMID:
23896308
38.

Variable definitions of the influenza season and their impact on vaccine effectiveness estimates.

Sullivan SG, Tay EL, Kelly H.

Vaccine. 2013 Sep 13;31(40):4280-3. doi: 10.1016/j.vaccine.2013.06.103. Epub 2013 Jul 9.

PMID:
23850417
39.

Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required.

Sullivan SG, Kelly H.

Clin Infect Dis. 2013 Aug;57(3):474-6. doi: 10.1093/cid/cit255. Epub 2013 Apr 25. No abstract available.

PMID:
23619811
40.

Factors associated with mortality of HIV-positive clients receiving methadone maintenance treatment in China.

Liu E, Rou K, McGoogan JM, Pang L, Cao X, Wang C, Luo W, Sullivan SG, Montaner JS, Bulterys M, Detels R, Wu Z; China's National Working Group on Methadone Maintenance Treatment.

J Infect Dis. 2013 Aug 1;208(3):442-53. doi: 10.1093/infdis/jit163. Epub 2013 Apr 16.

41.

A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.

Satgé D, Stiller CA, Rutkowski S, von Bueren AO, Lacour B, Sommelet D, Nishi M, Massimino M, Garré ML, Moreno F, Hasle H, Jakab Z, Greenberg M, von der Weid N, Kuehni C, Zurriaga O, Vicente ML, Peris-Bonet R, Benesch M, Vekemans M, Sullivan SG, Rickert C.

J Neurooncol. 2013 Mar;112(1):107-14. doi: 10.1007/s11060-012-1041-y. Epub 2013 Jan 11.

PMID:
23307327
42.

Bayesian regression in SAS software.

Sullivan SG, Greenland S.

Int J Epidemiol. 2013 Feb;42(1):308-17. doi: 10.1093/ije/dys213. Epub 2012 Dec 10. Erratum in: Int J Epidemiol. Int J Epidemiol. 2014 Oct;43(5):1667-8.

PMID:
23230299
43.

Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.

Kelly HA, Sullivan SG, Grant KA, Fielding JE.

Influenza Other Respir Viruses. 2013 Sep;7(5):729-37. doi: 10.1111/irv.12018. Epub 2012 Oct 19.

44.

The integration of multiple HIV/AIDS projects into a coordinated national programme in China.

Wu Z, Wang Y, Mao Y, Sullivan SG, Juniper N, Bulterys M.

Bull World Health Organ. 2011 Mar 1;89(3):227-33. doi: 10.2471/BLT.10.082552. Epub 2011 Feb 1.

45.

Scaling up prevention programmes to reduce the sexual transmission of HIV in China.

Rou K, Sullivan SG, Liu P, Wu Z.

Int J Epidemiol. 2010 Dec;39 Suppl 2:ii38-46. doi: 10.1093/ije/dyq211.

46.

Scaling up the national methadone maintenance treatment program in China: achievements and challenges.

Yin W, Hao Y, Sun X, Gong X, Li F, Li J, Rou K, Sullivan SG, Wang C, Cao X, Luo W, Wu Z.

Int J Epidemiol. 2010 Dec;39 Suppl 2:ii29-37. doi: 10.1093/ije/dyq210.

47.

Missed opportunities for HIV testing and counselling in Asia.

Sullivan SG, Wu Z, Detels R.

AIDS. 2010 Sep;24 Suppl 3:S49-53. doi: 10.1097/01.aids.0000390089.60682.26. Review. No abstract available.

PMID:
20926928
48.

Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.

Sullivan SG, Hirsch HH, Franceschi S, Steffen I, Amari EB, Mueller NJ, Magouras I, Biggar RJ, Rickenbach M, Clifford GM; Swiss HIV Cohort Study.

AIDS. 2010 Sep 10;24(14):2245-52. doi: 10.1097/QAD.0b013e32833b7830.

PMID:
20543658
49.

Stigmatizing attitudes and behaviors toward PLHA in rural China.

Sullivan SG, Xu J, Feng Y, Su S, Xu C, Ding X, Gao Y, Dou Z, Wu Z; China CIPRA Project 2 Team.

AIDS Care. 2010 Jan;22(1):104-11. doi: 10.1080/09540120903012528.

PMID:
20390487
50.

Attitudes towards circumcision among Chinese men.

Sullivan SG, Ma W, Duan S, Li F, Wu Z, Detels R.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):238-40. doi: 10.1097/QAI.0b013e31818d5e27. No abstract available.

PMID:
19155772

Supplemental Content

Loading ...
Support Center